Last Saturday (08.06.24) our iQMedix Oncology Congress took place with participants from all over Germany, Switzerland and Austria. We spent the day at Cubex One in Mannheim with great contributions from experienced doctors, researchers and our iQMedix managing directors.
Our managing directors Dr. Bernd Becker and Dr. Reinhard Becker informed the audience about the topic: "Why actually tumor expression diagnostics" and Dr. Bert Steffan spoke about the "Possibilities and limitations of liquid biopsy".
With exciting presentations by Dr. Wessolly on "Complementary oncology - methods and successes", Dr. Brockmann to "Long-lasting success with combined off-label therapies" and Dr. Kilarski about her "Successes of the complementary supplementation of oncological guideline therapy" the participants were able to learn a lot about the methods used and their successes.
Looking to the future, Prof. Dr. Scheider spoke about her scientific findings on "Glioblastoma, immunity and the influence of metabolic polymorphisms" and Dr. Kremoser gave us an insight into the "new developments in cancer therapeutics".
We would like to thank all congress participants and look forward to the next time.
